IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results
Placentia, California--(Newsfile Corp. - February 14, 2022) - InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter of 2022, ending December 31, 2021, compared to revenues and net income of $201,255 and $67,663, respectively, for its first fiscal quarter of 2021. The first fiscal quarter of 2022 earnings benefitted from its second government PPP loan forgiveness much...
2022-02-14 8:13 AM EST
IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal 2021 Results
Placentia, California--(Newsfile Corp. - December 8, 2021) - InVitro International (OTC Pink: IVRO) announced today that fiscal year 2021 sales for the year ending on September 30th topped $1M for the third consecutive year at $1,003,403. Though off 9% for the year, second half sales were up 47% versus the same period last year. Fiscal 2021 net income of $93,522 (including PPP forgiveness of $106,665) was nearly double the fiscal 2020 net income. In addition, IVRO finished fiscal 2021 with...
2021-12-08 9:00 AM EST
InVitro Announces Appointment of Investor Relations Partners
Placentia, California--(Newsfile Corp. - May 25, 2021) - InVitro International, Inc. (OTC Pink: IVRO) today announced the appointment of Investor Relations Partners (IRP) to provide external investor relations services to InVitro. IRP is an investor relations and public relations firm representing and advising micro to mega market cap companies, with a collective 50+ years of direct capital market experience. "With our continued financial improvements, recovering economy and improved...
2021-05-25 8:00 AM EDT